Coxsackievirus B5 virus-like particle vaccine exhibits greater immunogenicity and immunoprotection than its inactivated counterpart in mice

Seroprevalence of group B Coxsackieviruses: retrospective study in an Italian population

(2020) Ilaria Sciandra et al.   JOURNAL OF MEDICAL VIROLOGY

Epidemiology of Hand, Foot, and Mouth Disease Before and After the Introduction of Enterovirus 71 Vaccines in Chengdu, China, 2009–2018

(2020) Yutong Han et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Non-polio enterovirus infections in children with central nervous system disorders in Shanghai, 2016-2018: Serotypes and clinical characteristics

(2020) Jingjing Li et al.   JOURNAL OF CLINICAL VIROLOGY

Distribution of species enterovirus B in patients with central nervous system infections in São Paulo State, Brazil

(2020) Rita de Cássia Compagnoli Carmona et al.   JOURNAL OF MEDICAL VIROLOGY

Seroepidemiology of coxsackievirus B5 in infants and children in Jiangsu province, China

(2017) Fan Gao et al.   Human Vaccines & Immunotherapeutics

Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections

(2016) Chaoyun Shen et al.   VACCINE

Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges

(2016) Qin Yan et al.   VACCINE

Coxsackievirus B5 Infection Induces Dysregulation of microRNAs Predicted to Target Known Type 1 Diabetes Risk Genes in Human Pancreatic Islets

(2015) Ki Wook Kim et al.   DIABETES

Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice

(2013) Hui Zhao et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Recombination in human coxsackievirus B5 strains that caused an outbreak of viral encephalitis in Henan, China

(2013) Hongxia Ma et al.   ARCHIVES OF VIROLOGY

Neutralizing Antibodies Induced by Recombinant Virus-Like Particles of Enterovirus 71 Genotype C4 Inhibit Infection at Pre- and Post-attachment Steps

(2013) Zhiqiang Ku et al.   PLoS One

Novel and Predominant Pathogen Responsible for the Enterovirus-Associated Encephalitis in Eastern China

(2013) Lei Zhang et al.   PLoS One

Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice

(2013) Hao-Yang Li et al.   VACCINE

Coxsackievirus B5, associated with neurological hand, foot and mouth disease, China

(2012) Y.F. Hu et al.   JOURNAL OF INFECTION

A coxsackievirus B5-associated aseptic meningitis outbreak in Shandong Province, China in 2009

(2012) Peng Chen et al.   JOURNAL OF MEDICAL VIROLOGY

Full Genome Sequence of a Novel Coxsackievirus B5 Strain Isolated from Neurological Hand, Foot, and Mouth Disease Patients in China

(2012) Y. F. Hu et al.   JOURNAL OF VIROLOGY

Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis

(2012) L. Zhang et al.   VACCINE

Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes

(2011) D. Hober et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Characterization of a Putative Ancestor of Coxsackievirus B5

(2010) M. Gullberg et al.   JOURNAL OF VIROLOGY

Hepatitis B vaccines: Protective efficacy and therapeutic potential

(2010) M.-L. Michel et al.   PATHOLOGIE BIOLOGIE

Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield

(2010) Cheng-Yu Chung et al.   VACCINE

Enteroviruses in Spain over the decade 1998–2007: Virological and epidemiological studies

(2009) G. Trallero et al.   JOURNAL OF CLINICAL VIROLOGY

Crystallization and preliminary X-ray diffraction analysis of recombinant hepatitis E virus-like particle

(2008) Che-Yen Wang et al.   Acta Crystallographica Section F-Structural Biology and Crystallization Communications